Calton & Associates, Inc. Zoetis Inc. Transaction History

Calton & Associates, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$181.39 - $234.03 $149,283 - $192,606	-823 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$193.69 - $247.03 $159,406 - $203,305	823 New	823 $200,000
Q1 2021 May 03, 2021	SELL	$144.0 - $169.39 $188,352 - $221,562	-1,308 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$157.07 - $174.35 $48,063 - $53,351	-306 Reduced 18.96%	1,308 $217,000
Q3 2020 Oct 30, 2020	BUY	$137.1 - $165.37 $221,279 - $266,907	1,614 New	1,614 $267,000
Q2 2018 Aug 10, 2018	SELL	$79.9 - $89.2 $419,235 - $468,032	-5,247 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$71.51 - $84.69 $72,439 - $85,790	1,013 Added 23.93%	5,247 $438,000
Q4 2017 Feb 05, 2018	BUY	$63.24 - $72.8 $267,758 - $308,235	4,234	4,234 $328,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.